Gene · 407047
Papers2,619
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,619
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges and promise of targeting miRNA in rheumatic diseases: a computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms. | Front Immunol | 2023 | 38264662 | PubTator, text mining | PubMed |
| Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction. | Front Cardiovasc Med | 2023 | 38259314 | PubTator, text mining | PubMed |
| Current Research on Molecular Biomarkers for Colorectal Cancer in Stool Samples. | Biology (Basel) | 2023 | 38248446 | PubTator, text mining | PubMed |
| The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis. | Ann Med | 2023 | 38233735 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Key Regulators in Lung Cancer. | Int J Mol Sci | 2023 | 38203731 | PubTator, text mining | PubMed |
| The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. | Front Immunol | 2023 | 38193092 | PubTator, text mining | PubMed |
| MiR-96-5p Suppresses Progression of Arsenite-Induced Human Keratinocyte Proliferation and Malignant Transformation by Targeting Denticleless E3 Ubiquitin Protein Ligase Homolog. | Toxics | 2023 | 38133379 | PubTator, text mining | PubMed |
| The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges. | Mol Ther Oncolytics | 2023 | 38130701 | PubTator, text mining | PubMed |
| Circulating small extracellular vesicles microRNAs plus CA-125 for treatment stratification in advanced ovarian cancer. | J Transl Med | 2023 | 38129848 | PubTator, text mining | PubMed |
| miR-9 utilizes precursor pathways in adaptation to alcohol in mouse striatal neurons. | Adv Drug Alcohol Res | 2023 | 38116240 | PubTator, text mining | PubMed |
| Mapping knowledge structure and themes trends of cancer-associated fibroblasts: a text-mining study. | Front Mol Biosci | 2023 | 38111465 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| Emerging Microfluidic Tools for Simultaneous Exosomes and Cargo Biosensing in Liquid Biopsy: New Integrated Miniaturized FFF-Assisted Approach for Colon Cancer Diagnosis. | Sensors (Basel) | 2023 | 38067805 | PubTator, text mining | PubMed |
| Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care. | Cancers (Basel) | 2023 | 38067237 | PubTator, text mining | PubMed |
| MiR-20b Tissue Expression Level Displays the Diagnostic Value in Papillary Thyroid Carcinoma. | Med J Islam Repub Iran | 2023 | 38021380 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in glioma progression: insights into tumor microenvironment dynamics and therapeutic implications. | Front Cell Dev Biol | 2023 | 38020906 | PubTator, text mining | PubMed |
| ALOX5AP is a new prognostic indicator in acute myeloid leukemia. | Discov Oncol | 2023 | 37994961 | PubTator, text mining | PubMed |
| A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension. | Noncoding RNA | 2023 | 37987360 | PubTator, text mining | PubMed |
| Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia. | Hematol Rep | 2023 | 37987321 | PubTator, text mining | PubMed |
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407047/papers?page=3